Dermatology · Philadelphia, PA
NPI
1689609281
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
3400 Spruce Street, 2 Rhoads Pavilion
Philadelphia, PA, 19104
Phone (215) 662-2737
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
531 services
Medicare patients, 2024
210
Average age 71
Drug cost, 2024
$792K
1,311 prescriptions
Company payments, 2025
$159K
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victoria P Werth was code 99214 (office e&m - established), 293 times for 186 patients. In total Victoria P Werth billed 531 services in 16 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 293 | 186 | $72.95 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 156 | 123 | $12.87 | $2,008 |
| 99204 Office E&M - New | Facility | 36 | 36 | $100.30 | $3,611 |
By year: 2022 $25K for 338 services; 2023 $27K for 360 services; 2024 $28K for 531 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victoria P Werth prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 182 prescriptions and refills. In total Victoria P Werth wrote 1,311 Medicare prescriptions that cost $792K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 182 | 416 | 51 | $8,181 |
| Mycophenolate Mofetil Generic | 145 | 280 | 39 | $33K |
| Prednisone Generic | 144 | 201 | 38 | $1,135 |
| Methotrexate Methotrexate Sodium | 126 | 204 | 26 | $2,678 |
| Clobetasol Propionate Generic | 109 | 117 | 60 | $4,287 |
| Triamcinolone Acetonide Generic | 82 | 91 | 54 | $766 |
| Dapsone Generic | 80 | 154 | 24 | $9,473 |
| Dupixent Pen Dupilumab | 51 | 53 | 11 | $187K |
| Doxycycline Hyclate Generic | 32 | 83 | Under 11 | $6,190 |
| Tacrolimus Generic | 29 | 29 | 12 | $1,854 |
| Dexamethasone Generic | 29 | 36 | Under 11 | $815 |
| Ketoconazole Generic | 22 | 22 | Under 11 | $305 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 22 | 22 | Under 11 | $186K |
| Valacyclovir Valacyclovir Hcl | 16 | 48 | Under 11 | $720 |
| Chloroquine Phosphate Generic | 15 | 39 | Under 11 | $1,738 |
Brand drugs: - claims; generic drugs: 1,156 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victoria P Werth $159K ($154K in general payments such as food, travel and fees and $4,281 for research) from 24 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $63K.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 42 | $63K |
| Merck Sharp & Dohme LLC MRK | 21 | $21K |
| Merck KGaA MRK.DE | 5 | $18K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $9,060 |
| Biogen, Inc. BIIB | 13 | $8,425 |
| Genzyme Corporation SNY | 1 | $7,688 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $7,550 |
| AstraZeneca UK Limited AZN | 9 | $7,465 |
| Merck Healthcare KGaA | 2 | $3,084 |
| EMD Serono Research & Development Institute, Inc. MRK.DE | 1 | $2,500 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.